RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 CYT003-QbG10 Not Effective in Uncontrolled Allergic Asthma
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 11
SP 18
OP 19
DO 10.1177/155989771411011
UL http://mdc.sagepub.com/content/14/11/18.abstract
AB Treatment with the A-type CpG oligodeoxynucleotide CYT003-QbG10 did not improve asthma control or lung function in patients with allergic asthma not adequately controlled with inhaled corticosteroids. This article presents data from the Randomized, Placebo-Controlled, Phase IIb Dose-Finding Study of CYT003-QbG10, a TLR9-Agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma [NCT01673672; Casale T et al. Am J Respir Care Med 2014].